Publications | PubMed=978138; DOI=10.1084/jem.144.4.873 Shiku H., Takahashi T., Oettgen H.F., Old L.J. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J. Exp. Med. 144:873-881(1976) PubMed=1067619; DOI=10.1073/pnas.73.9.3278 Carey T.E., Takahashi T., Resnick-Silverman L.A., Oettgen H.F., Old L.J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc. Natl. Acad. Sci. U.S.A. 73:3278-3282(1976) DOI=10.1007/BF00199208 Bruggen J., Sorg C., Macher E. Membrane associated antigens of human malignant melanoma V: Serological typing of cell lines using antisera from nonhuman primates. Cancer Immunol. Immunother. 5:53-62(1978) DOI=10.1007/978-1-4615-7228-2_39 Houghton A.N., Oettgen H.F., Old L.J. Malignant melanoma. Current status of the search for melanoma-specific antigens. (In) Immunodermatology. Comprehensive Immunology, Vol 7; Safai B., Good R.A. (eds.); pp.557-576; Springer; Boston (1981) DOI=10.1007/BF00205883 Bruggen J., Macher E., Sorg C. Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma. Cancer Immunol. Immunother. 10:121-127(1981) PubMed=6895502; DOI=10.1002/eji.1830111015 Johnson J.P., Demmer-Dieckmann M., Meo T., Hadam M.R., Riethmuller G. Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin. Eur. J. Immunol. 11:825-831(1981) PubMed=6555061; DOI=10.1007/BF00199165 Bruggen J., Sorg C. Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies. Cancer Immunol. Immunother. 15:200-205(1983) PubMed=7646526; DOI=10.1006/bbrc.1995.2187 Artuc M., Nurnberg W., Czarnetzki B.M., Schadendorf D. Characterization of gene regulatory elements for selective gene expression in human melanoma cells. Biochem. Biophys. Res. Commun. 213:699-705(1995) PubMed=22970293; DOI=10.1371/journal.pone.0044707 Zhao R.Y., Mifsud N.A., Xiao K., Chan K.-F., Oveissi S., Jackson H.M., Dimopoulos N., Guillaume P., Knights A.J., Lowen T., Robson N.C., Russell S.E., Scotet E., Davis I.D., Maraskovsky E., Cebon J.S., Luescher I.F., Chen W.-S. A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen. PLoS ONE 7:E44707-E44707(2012) |